Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

638 recalls, newest first

Class II · Moderate risk

Atorvastatin Calcium Tablets

Presence of foreign substance: Foreign matter has been identified as latex glove in one lot of Atorvastatin Calcium Tablets USP 40 mg.

Terminated Particulate / foreign matter Sun Pharmaceutical Industries, Inc. NDC 63304-829-05 D-1047-2020
Class III · Low risk

Sodium Chloride Ophthalmic Ointment USP

Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.

Terminated Particulate / foreign matter Akorn, Inc. NDC 17478-622-35 D-0859-2020
Class II · Moderate risk

Major Extra Strength Acetaminophen Tablets

Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.

Terminated Particulate / foreign matter Contract Pharmacal Corporation NDC 0904-6730-60 D-0858-2020
Class II · Moderate risk

Leader Extra Strength Acetaminophen Tablets

Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.

Terminated Particulate / foreign matter Contract Pharmacal Corporation NDC 7000-0036-1 D-0857-2020
Class II · Moderate risk

Atorvastatin Calcium Tablets

Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg.

Terminated Particulate / foreign matter Graviti Pharmaceuticals Private Limited NDC 70377-027-11 D-0832-2020
Class I · High risk

Ketorolac Trom

Presence of Particulate Matter: Medication relabeled at facility was recalled by the manufacturer due to small black particles noticed during routine visual inspection. of retain samples.

Terminated Particulate / foreign matter RemedyRepack Inc. NDC 70518-1239-00 D-0867-2020
Class II · Moderate risk

Ibuprofen Oral Suspension USP

Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Terminated Particulate / foreign matter Preferred Pharmaceuticals, Inc NDC 68788-7268-01 D-0531-2020
Class II · Moderate risk

Gabapentin Capsules

Presence of Foreign Tablets/Capsules: One Losartan/HCTZ tablet was found in Gabapentin 1000 count bottles..

Terminated Particulate / foreign matter AuroMedics Pharma LLC NDC 65682-198-99 D-0653-2020
Class II · Moderate risk

fentaNYL 550 mcg/55 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1274-50 D-0572-2020
Class II · Moderate risk

fentaNYL 1500 mcg/30 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1180-79 D-0570-2020
Class II · Moderate risk

fentaNYL 2500 mcg/50 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1436-76 D-0569-2020
Class II · Moderate risk

fentaNYL 800 mcg/200 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1436-76 D-0568-2020

Recalls by year